Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
Recursion Pharmaceuticals Announces Dr. H. Perry Fell as the First Member of Business Advisory Panel
Recursion Pharmaceuticals, a biotech start-up in Salt Lake City today announced the formation of its Business Advisory Panel. The first appointment to the Advisory Panel is H. Perry Fell, MBA, Ph.D. Perry is a distinguished scientist and leader who most prominently co-founded Seattle Genetics (NASDAQ: SGEN) and served as its CEO from start-up through IPO. - June 05, 2014 - Recursion Pharmaceuticals
Solvo Biotechnology, the Transporter Company and Qualyst Transporter Solutions Execute a License to B-Clear® Services
Agreement Supporting Use of Qualyst’ s Patented B-CLEAR® Technology for Services offered by Solvo Biotechnology - May 29, 2014 - Solvo Biotechnology
Life Science Strategy Group Launches the OutsourcePharma Advisory Board
Online community dedicated to pharmaceutical sponsors provides open forum to discuss drug development and outsourced Contract Research Organization (CRO) services. - May 28, 2014 - Life Science Strategy Group, LLC
Jane Rohlf, MD & Premier Research Join Wake Research: New Investigational Site Added to Established Organization of Integrated Clinical Research Investigational Site
Raleigh-based Wake Research (Wake Research Associates, L.L.C.) announces an affiliation with Dr. Jane Rohlf and Premier Research, of Trenton, New Jersey. “Dr. Rohlf brings wealth of research expertise and her site fit well into our strategic plan to offer Biopharmaceutical Industry a broad... - May 24, 2014 - Wake Research Associates
Northeastern M.D.s to Gather for Presentation by Dr. Emil J. Haldey, Leading Pharmaceutical Compounding Expert
The prestigious National Medical Association will host a seminar on Friday featuring Dr. Emil J. Haldey, a doctor of pharmacy and a leader in the specialized field of pharmaceutical compounding. The event will take place May 23, beginning at 2 p.m., during the National Medical Association Annual... - May 22, 2014 - HALDEY Pharmaceutical Compounding
Medcom Kinetics Launches New Web Presence
Medcom Kinetics, Inc., a content and digital applications development company offering services to the pharmaceutical, biotech, and medical devices industries has enhanced its presence on the internet by updating its corporate website’s design, content, and layout, adding a uniquely appealing... - May 18, 2014 - Medcom Kinetics, Inc.
PBS Hightens Security in Prescription Blanks
Security in prescription forms and pads is an industry ridden with fraud and drug diversion. But the prescription blanks approved vendors are fighting back to improve tamper-resistant forms and pads. - May 15, 2014 - PBS - Professional Business Systems
Meeting the Requirements of the Pharmaceutical Supply Chain Initiative Webinar
The Pharmaceutical Supply Chain Initiative (PSCI) is an initiative of the major brands in the pharmaceutical sector. PSCI is a group of pharmaceutical companies that share a vision of improved social, economic and environmental outcome for all stakeholders of the pharmaceutical supply chain, focused particularly on acceptable working conditions, safe process and facilities, economic development and a cleaner environment for local communities. - May 13, 2014 - SGS
PharmSource Lead Sheet's New Platform Adds Functionality, Dynamic Interface
Real-time resource for CROs, CMOs seeking to build market share. - May 10, 2014 - PharmSource
Xcelthera Secures Patent for Large-Scale Production High Quality Human ES Cell Therapy Products
Xcelthera Inc and its joint research partner San Diego Regenerative Medicine Institute announced today that the USPTO has granted Patent No. 8,716,017 entitled “Technologies, Methods, and Products of Small Molecule-Directed Tissue and Organ Regeneration from Human Pluripotent Stem Cells”. - May 08, 2014 - Xcelthera Inc
LUZ Sponsors DA4S East Conference
Minority owned life science translation company continues support of Diversity Alliance for Science event. - May 04, 2014 - LUZ, Inc.
BiologicsCorp Launches Supernatant Protein Expression Service
BiologicsCorp proudly launches this new service - another first in the industry. They have tested many variables, including codon optimization, strain, charperones and foldases, and others. Give Supernatant Service a try, especially if your protein of interest could not be expressed in soluble form. BiologicsCorp is confident and can guarantee success - no soluble fraction for target protein, no payment for expression service. - April 25, 2014 - BiologicsCorp
CRO Analytics Announces Free Webinar on the Use of Validated Analytics to Improve Clinical Trial Management
This free webinar will be held on Wednesday, May 14, 10AM EST. - April 18, 2014 - CRO Analytics
Clinigen Group to Manage International Named Patient Program for Abiogen Pharma’s Nerixia® (Neridronic Acid)
Clinigen Group plc (‘Clinigen’ or the ‘Group’) (AIM: CLIN) and Abiogen Pharma SpA (‘Abiogen’) jointly announced today the initiation of a Named Patient Program, managed by Clinigen Global Access Programs (Clinigen GAP) to provide Nerixia® (neridronic acid),... - April 16, 2014 - Clinigen Group
Recursion Pharmaceuticals Announces Formation of Its Scientific and Technical Advisory Board
Recursion Pharmaceuticals is a start-up biotech firm in Salt Lake City with a goal of discovering new therapeutics for the treatment of rare genetic diseases. Recursion announced the formation of its Scientific and Technical Advisory Board today, along with the appointment of Dr. Anne Carpenter and Dr. Kirk Thomas as its first two members. - April 12, 2014 - Recursion Pharmaceuticals
Pharmacovigilance Market is Expected to Reach USD 5.0 Billion Globally in 2019: Transparency Market Research
Transparency Market Research Report Adds "Pharmacovigilance Market Clinical Trial Phases (Pre-Clinical Studies, Phase I, Phase II, Phase III, Phase IV or Post-Marketing Surveillance) and Service Providers - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" to its database. - April 12, 2014 - Transparency Market Research
Lucideon to Open Pharmaceutical Laboratories
Lucideon is pleased to announce that it has invested £1.5M in new pharmaceutical chemistry quality control (QC) testing laboratories, at its headquarters in Stoke-on-Trent. - April 10, 2014 - Lucideon
Dr. Kristy Ainslie Strengthens Drug Delivery Focus as She Becomes Advisor to Peptineo
Peptineo is pleased to welcome Dr. Ainslie to advisory board at Peptineo. Dr. Ainslie received her PhD in Chemical Engineering from Penn State, and after a short post doc in a start up company focused on biosensor development, Protiveris, she completed a post doc at UCSF. During her post doc, she... - April 08, 2014 - Peptineo
New Discussion Topics, New Speakers on Agenda for 3rd Annual Pharmaceutical Managed Markets & Payer Marketing Strategies Conference
Session Topics Include Progression of Medicare Programs and Streamlining Medical Benefit Management Process - April 05, 2014 - Q1 Productions
ALPCO Expands EuroFlow™ Product Offering with the Addition of Plasma Cell Dyscrasias Screening Tube
ALPCO has expanded EuroFlow™ product offering with addition of the Plasma Cell Screening Tube from Cytognos S.L. - April 03, 2014 - ALPCO
Global Endocrine Testing Market Projected to Reach USD 2.03 Billion by 2019: Transparency Market Research
Transparency Market Research has added a new report titled “Endocrine Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019” to its... - April 03, 2014 - Transparency Market Research
OsoBio Appoints Catherine Buck Director of Manufacturing
Buck has 20-plus years of experience managing pharma and commercial manufacturing plants. - April 02, 2014 - OSO BioPharmaceuticals Manufacturing, LLC
Peptineo Adds Dr. Yoganathan to Advisory Board to Strengthen Biomaterials Development and Commercialization
Dr. Yoganathan is a SME in the areas of biomaterials and drug delivery - having collaborated and worked closely with thought-leaders in the field such as Dr. Robert Langer, Dr. Kazunori Kataoka, Dr. Michael V. Sefton and Dr. Christine Allen. He is an expert in manipulating material properties to... - March 31, 2014 - Peptineo
Revolutionary Science Teaching Model Transforms Diabetes HbA1c Blood Test Into Hand-Held Education
Biologic Designs launches first crowdfunding campaign to introduce its latest educational product, the Glycated Hemoglobin A1c (HbA1c) Teaching Model. The biologic protein marker from the HbA1c blood test is no longer just a number; it is a physiological process that can be demonstrated to patients through tactile science education. - March 29, 2014 - Biologic Designs LLC
Summit Biosciences Announces Successful FDA Preapproval Inspection for Manufacturing of Nasal Spray Drug Product
Summit Biosciences Inc., a specialty pharmaceutical company, is pleased to announce that the manufacturing facility in Lexington, Kentucky has successfully passed its first preapproval inspection by the Food and Drug Administration (FDA). The inspection for a new nasal spray drug product, which... - March 28, 2014 - Summit Biosciences Inc.
Peptineo Announces Appointment of David M. Wyatt to Advisory Board
Peptineo is pleased to announce the appointment of David M. Wyatt to their advisory board. David has had over 25 years of technical and business experience in the development of controlled release pharmaceutical products. He has held senior management positions in sales and business development,... - March 27, 2014 - Peptineo
New Location, New Speakers Set for 3rd Annual Strengthening Patient Advocacy Relations Across the Life Sciences Conference
Partnering with PCORI, Building Effective Industry Alliances, Utilizing Non-Branded Patient Websites Among Discussion Topics. - March 21, 2014 - Q1 Productions
OnkoDataMed Joins ACM, ICRC-Weyer in Medis Research Group
Medis Research Group, a strategic alliance of Berlin-based clinical research organizations, has recently been joined by yet another CRO from the Berlin area, oncology specialists OnkoDataMed GmbH. - March 19, 2014 - ICRC-Weyer GmbH
White Paper: The Hazards of Unapproved Drugs and Importance of Utilizing Approved Drugs
“Continued use of non-approved drugs when a safe, FDA-approved product is available is not in the public interest and can lead to legal lawsuits.” -Cindy Ippoliti, Pharm.D., NYP/Weill Cornell - March 17, 2014 - Expect Advertising, Inc.
Annodyne Announces the Launch of Its New Division: AIM Rx
AIM Rx is a new full-service digital health care agency with a concentrated focus on complex specialty markets. - March 09, 2014 - Annodyne, Inc.
Disruptive Innovation in Clinical Trials
Dataline Software is delighted to announce its attendance at the inaugural "Disruptive Innovation in Clinical Trials" conference in London on 4th & 5th March 2014, where it will be showcasing its latest eClinical solutions. Introducing TrialViz; Trial feasibility and recruitment. At... - March 01, 2014 - Dataline Software
Robert M. Adams Recognized by Strathmore's Who's Who Worldwide Publication
Robert M. Adams of Las Vegas, Nevada has been included in the Strathmore’s Who’s Who Worldwide Edition for his outstanding contributions and achievements in the field of law. About Robert M. Adams Mr. Adams is a Partner with the law firm of Eglet Wall Christiansen, and has over 15... - March 01, 2014 - Strathmore Worldwide
Triad to Provide Global Investment Banking for the Healthcare Industry
Triad Securities, a leading Wall St brokerage firm, is pleased to announce the formation of Triad Healthcare Partners, a division of Triad Securities Corp. The new division, headed by Andrew Hirschberg, will provide investment banking services, focused on the specialty pharmaceutical sector. - February 28, 2014 - Triad Securities
New Drug Safety/Pharmacovigilance Report Training by Well-Known Safety Expert
Drug Safety Navigator, LLC will proudly host an interactive drug safety webinar with Dr. Barton Cobert, global pharmacovigilance expert and published author, on the challenges of the new Periodic Benefit-Risk Evaluation Reports (PBRERs) on March 26 at 11:00 AM EST (USA). - February 28, 2014 - Drug Safety Navigator, LLC
Melissa Easy, Founder of DrugDev Selected as a Finalist for IIR Partnerships Woman of the Year
IIR’s Partnerships in Clinical Trials named Melissa Easy, founder of DrugDev as a finalist for the IIR Partnerships Woman of the Year Award. The award was created to honor exceptional women in the clinical trials industry who have successfully achieved the highest levels of professional... - February 28, 2014 - Clinical Financial Services
Crack the Code: Demystify the Success Factors for Career Development
Sino-American Pharmaceutical Professional Associations (SAPA) will hold the 2014 Career Development Workshop: “Crack the Code: Demystify the Success Factors for Career Development” on Saturday, March 1st, 2014, 9 am - 5 pm at the Rutgers University (675 Hoes Lane West, Piscataway, New... - February 22, 2014 - Sino-American Pharmaceutical Professionals Association
IMAPAC’s 3rd Biologics Korea Gathering to Bring Together Over 150 Leading Industry Players
With support from the Korean Biologics Manufacturers Association (KPMA), IMAPAC will organize the 3rd Annual Biologics World Korea 2014 conference to take place from 22-24 April 2014, in Seoul, Korea. - February 21, 2014 - IMAPAC
Strathmore’s Who’s Who Names Mario C. Calanna the Mentor of the Year 2014
Mario C. Calanna, of Woree, Queensland, Australian, has been named the Mentor of the Year by Strathmore’s Who’s Who Registry for providing advice, information and support in Total Health Solutions. - February 20, 2014 - Strathmore Who's Who
Metrics Inc. Expands with Fast-Track Pharmaceutical Product Development Laboratory
Along with Gerteis Mini-Pactor®, capital investments reflect ongoing commitment to contract services - February 20, 2014 - Metrics, Inc.
Healthy Lifestyles LLC Announces Prostatection™ All-Natural Prostate Health Supplement That Helps Support Prostate Health
A team of physicians consisting of two board certified urologists, one of which trained in Oncology at Sloan Kettering-Cancer Center, and an Emergency Medicine physician with a background in Bio-Chemistry have developed a groundbreaking all-natural organic supplement designed to support and maintain healthy prostates in men. - February 19, 2014 - Healthy Lifestyles LLC
HeMemics Announces Election of Larry Simpson to Its Board of Directors
Election of Larry Simpson to HeMemics Board of Directors - February 15, 2014 - HeMemics Biotech
HeMemics Type C Meeting with FDA Blood Applications Division
HeMemics to meet with the FDA to discuss which of the available paths that HeMemics Platelet Additive Solution (HemSol™) may take in pursuit of FDA approval and commercialization - February 15, 2014 - HeMemics Biotech
Mayne Pharma USA Acquires Branded Products
Mayne Pharma USA has acquired select brands from Forest Laboratories Inc. for $10M plus $2M performance-based earn-out; purchase complements brand acquisition from Shionogi completed in November 2013. - February 14, 2014 - Metrics, Inc.
Dr. Emil J. Haldey to Address Physicians in Field of Podiatric Medicine
Joint Session of American Board of Foot Surgeons and American Association of Medical Foot Specialists to welcome pharmaceutical compounding expert. - February 12, 2014 - HALDEY Pharmaceutical Compounding
VIRUN® & Amway Open Innovation Push for More Creativity and Technology; Introducing Unknown Thoughts in Industry
Virun, and Amway Open Innovation, team-up to express their interest and efforts to foster creativity, invention, and innovation with foods, beverages and supplements. New product development is more difficult today than ever before; increased regulations, competition, market saturation and consumer perception make it difficult to introduce new products that, not only stand-out, but are what consumers will purchase and re-purchase. - February 11, 2014 - VIRUN
Q1 Productions to Host 4th Annual Pharmaceutical Sales Training and Development Conference This March
Crafting Global Learning Plans and Engaging Tenured Sales Representatives Among Newly Added Session Topics - February 08, 2014 - Q1 Productions
Inaugural Pharmaceutical Multi-Channel Marketing Strategy Conference Slated for April 2014
E-Prescribing, Omni-Channel Marketing Among Session Hot Topics - January 30, 2014 - Q1 Productions
Stefan Cross Appointed President of Mayne Pharma USA
Cross will manage all U.S. operations, including contract services and pharmaceutical products. - January 30, 2014 - Metrics, Inc.
Dr. George Tegos Joins Advisory Board at Peptineo to Guide Antimicrobial Pipeline and Technology Development
Peptineo, a biotechnology company focused on value recovery in Pharma, announces the appointment of George Tegos, PhD, to the company's Scientific Advisory Board. "We are extremely pleased that Dr. Tegos has joined the Peptineo Scientific Advisory Board. Dr. Tegos is recognized as an emerging... - January 29, 2014 - Peptineo
More Pharma Deploys Sales Vision CRM on iPad
More Pharma, one of the leading Mexican pharmaceuticals has implemented the winning and globally most popular offline iPad version of Sales Vision Pharma CRM. - January 26, 2014 - Media-soft